Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorThe University of Hong Kong
About this trial
This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.
Eligibility criteria
Qualifiers
Patients aged 40 or older
Scheduled for elective upper endoscopy
Disqualifiers
Pregnant women,
Inability to provide written informed consent
Prior gastrectomy, and
Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses
Trial design
Treatments tested in this trial
- AI-assisted upper gastrointestinal endoscopy
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov